Clinical Trial: A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441252) titled 'A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight' on Feb. 06.

Brief Summary: The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or overweight and elevated liver fat content, when administered in conjunction with reduced-calorie diet and increased physical activity.

Study Start Date: March 09

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity and Elevated Liver Fat

Intervention: DRUG: Maridebar...